Govt’s 45-lakh dose order comes as a booster shot for Covaxin

DCGI panel seen scrapping ‘clinical trial mode’ condition for the Bharat Biotech vaccine, based on 81 per cent efficacy report
Read More

Leave a Comment

Your email address will not be published. Required fields are marked *